COPE Advertising options Cell Sciences Inc COGITO ERGO COPE ADVERTISING SPACE

COPE Homepage Bottom of page Previous entry:
Late response genes
Next entry:
Random entry:
Semaphorin Q
Search COPE:

Please donate

If COPE helps you,
please help me to continue my work.
Make a donation you can afford.


[lymphokine-activated tumor inhibition] This is an experimental variant of the lymphokine mediated immunotherapy of tumors (see also: Adoptive immunotherapy) involving the use of LAK cells (lymphokine-activated killer cells).

This approach essentially involves local injections of low doses of IL2 into the tumor mass to induce non-reactive lymphocytes accumulated in the tumor mass to develop into reactive cells. A similar activation of cells has been observed also with the local injection of IL4 and immunoreactive peptide fragments of IL1.

Experimentally LATI has been successful in the treatment of poorly immunoreactive tumors.

Copyright 2012 by H IBELGAUFTS. All rights reserved.


See REFERENCES for entry LATI.

Click BACKLINKS to see which COPE entries contain the term LATI .

COPE Homepage Top of Page

SUPPORT COPE | Intro | Subdictionaries | New Entries | Contribute data | COPE Credentials
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Please inquire. COPE is interested in contacts with corporate sponsors appreciating and committed to communication biology

              Created, developed, and maintained by Prof Dr H Ibelgaufts              
About the author of COPE
  |    Contact COPE   |    Terms & Conditions

U L T R A   P O S S E   N E M O   O B L I G A T U R